In cancers, the uPA system catalyzes plasminogen to plasmin and directly induces the degradation of the ECM components, which leads to the activation of metalloproteinases and the release of latent growth factors (Laufs, Schumacher & Allgayer, 2006). Here, PLAU is linked to cancer.